ARCHIVES

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

NCAB Opposes Line Item for Centers

May 23, 1980

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987